The Company was incorporated as a public limited company under the Companies Act, 2013, in Hyderabad, Telangana, India, pursuant to a certificate of incorporation dated November 6, 2018 issued by the Registrar of Companies, Telangana, at Hyderabad. 2020 -Suven Pharmaceuticals Ltd. has issued Bonus Shares in the Ratio of 1:1. 2021 -CSIR-IICT and SUVEN Pharmaceuticals Ltd., joined hands for the process technology transfer and manufacture of anti COVID drugs Molnupiravir and 2-DG. 2022 -Advent to acquire significant stake in Suven Pharmaceuticals from Jasti family. -Suven Pharmaceuticals approves acquisition of Casper Pharma. |
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article